Walgreens Boots Alliance Inc. reported quarterly results that surpassed Wall Street’s expectations, easing pressure on the pharmacy chain as it mulls strategic options including a sale.
Revenue came to $39 billion for the fiscal quarter ended Nov. 30 — above the average analyst estimate and driven by higher prices for branded drugs and prescription volumes at the company’s US retail pharmacy division, it said Friday. Sales at the company’s international and US healthcare units also beat expectations, as did Walgreens’ adjusted profit.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.